These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 27177616)

  • 1. Exosomes from adipose-derived stem cells ameliorate phenotype of Huntington's disease in vitro model.
    Lee M; Liu T; Im W; Kim M
    Eur J Neurosci; 2016 Aug; 44(4):2114-9. PubMed ID: 27177616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracts of adipose derived stem cells slows progression in the R6/2 model of Huntington's disease.
    Im W; Ban J; Lim J; Lee M; Lee ST; Chu K; Kim M
    PLoS One; 2013; 8(4):e59438. PubMed ID: 23565152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipose-derived stem cell exosomes alleviate pathology of amyotrophic lateral sclerosis in vitro.
    Lee M; Ban JJ; Kim KY; Jeon GS; Im W; Sung JJ; Kim M
    Biochem Biophys Res Commun; 2016 Oct; 479(3):434-439. PubMed ID: 27641665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-27a reduces mutant hutingtin aggregation in an in vitro model of Huntington's disease.
    Ban JJ; Chung JY; Lee M; Im W; Kim M
    Biochem Biophys Res Commun; 2017 Jun; 488(2):316-321. PubMed ID: 28495533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant Huntingtin Inhibits αB-Crystallin Expression and Impairs Exosome Secretion from Astrocytes.
    Hong Y; Zhao T; Li XJ; Li S
    J Neurosci; 2017 Sep; 37(39):9550-9563. PubMed ID: 28893927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug resistance protein 1 reduces the aggregation of mutant huntingtin in neuronal cells derived from the Huntington's disease R6/2 model.
    Im W; Ban JJ; Chung JY; Lee ST; Chu K; Kim M
    Sci Rep; 2015 Nov; 5():16887. PubMed ID: 26586297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration.
    Lu B; Palacino J
    FASEB J; 2013 May; 27(5):1820-9. PubMed ID: 23325320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of mitochondrial function by stem cell-derived cellular components.
    Liu T; Im W; Lee ST; Ban JJ; Chai YJ; Lee M; Mook-Jung I; Chu K; Kim M
    Biochem Biophys Res Commun; 2014 Jun; 448(4):403-8. PubMed ID: 24802395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging Roles of Exosomes in Huntington's Disease.
    Ananbeh H; Vodicka P; Kupcova Skalnikova H
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomes as a potential messenger unit during heterochronic parabiosis for amelioration of Huntington's disease.
    Lee M; Im W; Kim M
    Neurobiol Dis; 2021 Jul; 155():105374. PubMed ID: 33940179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Slowed progression in models of Huntington disease by adipose stem cell transplantation.
    Lee ST; Chu K; Jung KH; Im WS; Park JE; Lim HC; Won CH; Shin SH; Lee SK; Kim M; Roh JK
    Ann Neurol; 2009 Nov; 66(5):671-81. PubMed ID: 19938161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomes from adipose-derived stem cells attenuate UVB-induced apoptosis, ROS, and the Ca
    Hong Y; Sun Y; Rong X; Li D; Lu Y; Ji Y
    Exp Cell Res; 2020 Nov; 396(2):112321. PubMed ID: 33045215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PINK1-induced mitophagy promotes neuroprotection in Huntington's disease.
    Khalil B; El Fissi N; Aouane A; Cabirol-Pol MJ; Rival T; Liévens JC
    Cell Death Dis; 2015 Jan; 6(1):e1617. PubMed ID: 25611391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington's disease.
    Hsiao HY; Chen YC; Chen HM; Tu PH; Chern Y
    Hum Mol Genet; 2013 May; 22(9):1826-42. PubMed ID: 23372043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of ginsenoside Rg3 and Rf for Huntington's disease.
    Lee M; Ban JJ; Won BH; Im W; Kim M
    In Vitro Cell Dev Biol Anim; 2021 Jun; 57(6):641-648. PubMed ID: 34128157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMPK-α1 functions downstream of oxidative stress to mediate neuronal atrophy in Huntington's disease.
    Ju TC; Chen HM; Chen YC; Chang CP; Chang C; Chern Y
    Biochim Biophys Acta; 2014 Sep; 1842(9):1668-80. PubMed ID: 24946181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The A2A adenosine receptor rescues the urea cycle deficiency of Huntington's disease by enhancing the activity of the ubiquitin-proteasome system.
    Chiang MC; Chen HM; Lai HL; Chen HW; Chou SY; Chen CM; Tsai FJ; Chern Y
    Hum Mol Genet; 2009 Aug; 18(16):2929-42. PubMed ID: 19443488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipose stem cell-derived nanovesicles inhibit emphysema primarily via an FGF2-dependent pathway.
    Kim YS; Kim JY; Cho R; Shin DM; Lee SW; Oh YM
    Exp Mol Med; 2017 Jan; 49(1):e284. PubMed ID: 28082743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Anti-Apoptotic Effect of ASC-Exosomes in an In Vitro ALS Model and Their Proteomic Analysis.
    Bonafede R; Brandi J; Manfredi M; Scambi I; Schiaffino L; Merigo F; Turano E; Bonetti B; Marengo E; Cecconi D; Mariotti R
    Cells; 2019 Sep; 8(9):. PubMed ID: 31540100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau hyperphosphorylation and deregulation of calcineurin in mouse models of Huntington's disease.
    Gratuze M; Noël A; Julien C; Cisbani G; Milot-Rousseau P; Morin F; Dickler M; Goupil C; Bezeau F; Poitras I; Bissonnette S; Whittington RA; Hébert SS; Cicchetti F; Parker JA; Samadi P; Planel E
    Hum Mol Genet; 2015 Jan; 24(1):86-99. PubMed ID: 25205109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.